Patents by Inventor Johannes Prins

Johannes Prins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200353048
    Abstract: A method of treating a metabolic disorder of the liver includes administering a therapeutic agent. The therapeutic agent includes an IL-22 polypeptide and an antigen-binding molecule. The IL-22 polypeptide is fused or otherwise conjugated, directly or indirectly, to the antigen-binding molecule, and the antigen-binding molecule is an antibody or antigen-binding fragment that includes heavy and light chain CDR sequences.
    Type: Application
    Filed: May 19, 2020
    Publication date: November 12, 2020
    Inventors: Michael McGuckin, Johannes Prins, Sumaira Hasnain
  • Patent number: 10695406
    Abstract: Disclosed are compositions and methods for modulating oxidative and/or endoplasmic reticulum (OER) stress. More particularly, the present invention discloses compositions and methods that target OER stress inhibitors to pancreatic cells for treating diseases associated with oxidative and/or OER stress, including metabolic disorders such as diabetes.
    Type: Grant
    Filed: May 27, 2015
    Date of Patent: June 30, 2020
    Assignee: The University of Queensland
    Inventors: Michael McGuckin, Johannes Prins, Sumaira Hasnain
  • Publication number: 20170143798
    Abstract: Disclosed are compositions and methods for modulating oxidative and/or endoplasmic reticulum (OER) stress. More particularly, the present invention discloses compositions and methods that target OER stress inhibitors to pancreatic cells for treating diseases associated with oxidative and/or OER stress, including metabolic disorders such as diabetes.
    Type: Application
    Filed: May 27, 2015
    Publication date: May 25, 2017
    Inventors: Michael McGUCKIN, Johannes PRINS, Sumaira HASNAIN
  • Publication number: 20050282733
    Abstract: The present invention is directed to methods and agents for modulating the differentiation potential and/or proliferation of preadipocytes. More particularly, the present invention discloses methods and agents for modulating a fibroblast growth factor (FGF) signaling pathway, especially the FGF-1 or FGF-2 signaling pathway, for treating or preventing adiposity-related conditions including, but not limited to, obesity, lipoma, lipomatosis, cachexia or lipodystrophy or the loss of adipose tissue in trauma or atrophic conditions.
    Type: Application
    Filed: December 23, 2004
    Publication date: December 22, 2005
    Inventors: Johannes Prins, Louise Hutley, Ross McGeary
  • Patent number: 4058341
    Abstract: A collapsible item of furniture such as a chair is disclosed as having a back-rest portion connected by a serrated means in continual meshed engagement with a serrated means connected to posterior leg portions so that the back-rest and posterior leg portions rotated concurrently with one another and relative to a seat or lying base. The serrated means are part of an articulating means comprising a pair of bowl-shaped housings encompassing the serrated means which rotate about stub shafts in the bowl-shaped housings. Anterior leg portions are connected at central locations to the front of the seat base and at upper ends to an arm rest means which, in turn, is connected to the back rest.
    Type: Grant
    Filed: April 9, 1976
    Date of Patent: November 15, 1977
    Inventor: Johannes Prins
  • Patent number: D365452
    Type: Grant
    Filed: August 15, 1994
    Date of Patent: December 26, 1995
    Assignee: Aquarius Casual Furniture Nederland B.V.
    Inventors: Wolf-Dieter Krause, Johannes Prins